Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:39 PM
Ignite Modification Date:
2025-12-24 @ 6:39 PM
NCT ID:
NCT00187057
Eligibility Criteria:
Inclusion Criteria:
* Patient must have a diagnosis of Ataxia-Telangiectasia (A-T).
* Patient must have a diagnosis of either acute lymphoblastic leukemia (ALL) or lymphoma (non-Hodgkin lymphoma or Hodgkin's disease).
* Patients with other malignancies (solid tumors, rare malignancies, or relapsed hematopoietic malignancies) will be eligible for the biologic studies of this protocol; they will receive best clinical management chemotherapy.
* Patients do not have to be previously untreated. If prior chemotherapy has already started (up through induction), therapy will be continued according to protocol at a clinically appropriate time point.
Exclusion Criteria:
* Patients who do not have a diagnosis of Ataxia Telangiectasia (A-T).
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
10 Years
Study:
NCT00187057
Study Brief:
Protocol Section:
NCT00187057